A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The study will compare the transmissible levels of poliovirus type-2 detected in stool samples collected at the time of the nOPV2 challenge and subsequent timepoints in 3 groups of newborns receiving an nOPV2 dose at birth and primed with 3 doses of IPV (6 - 10 - 14 weeks of age).
Epistemonikos ID: 720d6b865edcd7692cbc4352b51aab11c7839201
First added on: Apr 17, 2026